KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Signals

$18.44
+0 (+0%)
At Close: May 27, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 139 days ( -3.42 % )
Last Price $18.44 0 %
High/ Low $18.44 - $18.44 0%
Chg 7 Days N/A $18.44 $18.44
Chg 30 Days N/A $18.44 $18.44
Chg 12 mos 129.93 % $8.02 $18.44
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 78.51 % Width: 75.22 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $25.91 - $45.41 40.53 % - 146.23 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Nov 11, 2021 - 137 days
Long MA avg 12 mos Sell Apr 07, 2022 - 36 days
Short/Long MA avg 12 mos Sell Apr 07, 2022 - 36 days
Pivot Short Sell May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT